Type of Care:
Mental health treatment Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.):
Residential/24-hour residential
Facility Type:
Residential treatment center (RTC) for children
Pharmacotherapies:
Haloperidol Thioridazine Aripiprazole Lurasidone Olanzapine Quetiapine Risperidone Antipsychotics used in treatment of SMI
Treatment Approaches:
Activity therapy Cognitive behavioral therapy Couples/family therapy Dialectical behavior therapy Group therapy Individual psychotherapy Telemedicine/telehealth therapy
Facility Operation (e.g., Private, Public):
Private non-profit organization
Special Programs/Groups Offered:
Children/adolescents with serious emotional disturbance (SED)
Assessment/Pre-treatment:
Screening for tobacco use
Testing:
Metabolic syndrome monitoring Laboratory testing
Recovery Support Services:
Housing services
Facility Smoking Policy :
Smoking not permitted
Age Groups Accepted:
Children/Adolescents
Facility Vaping Policy:
Vaping not permitted
Ancillary Services:
Family psychoeducation Psychosocial rehabilitation services Case management service Integrated primary care services Education services